These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evolution of renal osteodystrophy in patients treated by continuous ambulatory peritoneal dialysis. El Shahat Y; Jacobs C; Issad B; Rottembourg J; Legrain M Adv Exp Med Biol; 1982; 151():429-40. PubMed ID: 7180661 [No Abstract] [Full Text] [Related]
3. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Coburn JW Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845 [No Abstract] [Full Text] [Related]
4. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088 [TBL] [Abstract][Full Text] [Related]
5. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis. Buccianti G; Bianchi ML; Valenti G Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771 [TBL] [Abstract][Full Text] [Related]
6. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis. Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132 [TBL] [Abstract][Full Text] [Related]
7. Reversal of adynamic bone disease by lowering of dialysate calcium. Haris A; Sherrard DJ; Hercz G Kidney Int; 2006 Sep; 70(5):931-7. PubMed ID: 16837920 [TBL] [Abstract][Full Text] [Related]
8. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Weinreich T; Passlick-Deetjen J; Ritz E Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324 [TBL] [Abstract][Full Text] [Related]
9. [Regression of extraosseous calcinosis in chronic ambulatory peritoneal dialysis treatment]. Haag B Z Urol Nephrol; 1989 Feb; 82(2):81-4. PubMed ID: 2728634 [TBL] [Abstract][Full Text] [Related]
11. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Aloni Y; Shany S; Chaimovitz C Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753 [TBL] [Abstract][Full Text] [Related]
13. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification]. Fournier A; Aparicio M Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056 [No Abstract] [Full Text] [Related]